Cargando…

Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study

OBJECTIVE: Between 2012 and 2017, the U.S. Food and Drug Administration (FDA) approved 10 antidiabetic indicated therapies. Due to the limited literature on voluntarily reported safety outcomes for recently approved antidiabetic drugs, this study investigated adverse drug reactions (ADRs) reported i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stottlemyer, Britney A., McDermott, Michael C., Minogue, Mackenzie R., Gray, Matthew P., Boyce, Richard D., Kane-Gill, Sandra L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272667/ https://www.ncbi.nlm.nih.gov/pubmed/37332887 http://dx.doi.org/10.1177/20420986231181334

Ejemplares similares

Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis
por: Giofrè, Chiara, et al.
Publicado: (2013)

Antiretroviral adverse drug reactions pharmacovigilance in Harare City, Zimbabwe, 2017
por: Mugauri, Hamufare, et al.
Publicado: (2018)

Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based Survey
por: Grizzle, Amy J, et al.
Publicado: (2019)

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
por: Dahlén, Amelia D., et al.
Publicado: (2022)

Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017
por: Skydel, Joshua J., et al.
Publicado: (2022)

Status of adverse drug reaction monitoring and pharmacovigilance in selected countries
por: Yadav, Sachdev
Publicado: (2008)

Adverse drug reactions reporting culture in Pharmacovigilance Programme of India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2014)

Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance
por: Sahu, Ram Kumar, et al.
Publicado: (2014)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
por: Hadi, Muhammad Abdul, et al.
Publicado: (2017)

Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance
por: Almandil, Noor B.
Publicado: (2016)

Pharmacovigilance and spontaneous adverse drug reaction reporting: Challenges and opportunities
por: Desai, Mira
Publicado: (2022)

New FDA approved antibacterial drugs: 2015-2017
por: Andrei, Stefan, et al.
Publicado: (2018)

Systematic Review of Efficacy and Safety of Newer Antidiabetic Drugs Approved from 2013 to 2017 in Controlling HbA1c in Diabetes Patients
por: Palanisamy, Sivanandy, et al.
Publicado: (2018)

An adverse drug reaction clinic: Breathing fresh life into the pharmacovigilance programme
por: Brashier, Dick B. S., et al.
Publicado: (2012)

Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis
por: Scicchitano, Francesca, et al.
Publicado: (2012)

Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India
por: Tandon, Vishal R., et al.
Publicado: (2015)

Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal
por: Shrestha, Sunil, et al.
Publicado: (2020)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

US Food and Drug Administration Review Time of Supplemental New Indication Approvals of Drugs and Biologics, 2017 to 2019
por: Dhodapkar, Meera M., et al.
Publicado: (2023)

Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022)

Drug_SNSMiner: standard pharmacovigilance pipeline for detection of adverse drug reaction using SNS data
por: Lee, Seunghee, et al.
Publicado: (2023)

An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021
por: Li, Xiaotong, et al.
Publicado: (2023)

Changing use of antidiabetic drugs in the UK: trends in prescribing 2000–2017
por: Wilkinson, Samantha, et al.
Publicado: (2018)

Gender differences in adverse event reports associated with antidiabetic drugs
por: Joung, Kyung-In, et al.
Publicado: (2020)

Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019
por: Dhodapkar, Meera, et al.
Publicado: (2021)

Pharmacy students’ knowledge and perceptions about adverse drug reactions reporting and pharmacovigilance
por: Rajiah, Kingston, et al.
Publicado: (2016)

Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
por: Fornasier, G., et al.
Publicado: (2018)

Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education
por: Khan, Zakir, et al.
Publicado: (2020)

Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study
por: Bansod, Kishor A, et al.
Publicado: (2020)

Fatal Events Associated with Adverse Drug Reactions in the Korean National Pharmacovigilance Database
por: Jo, Hyeong-Geun, et al.
Publicado: (2021)

Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study
por: Hernández García, Ernestina, et al.
Publicado: (2023)

Adverse drug reaction profile of microtubule-damaging antineoplastic drugs: A focused pharmacovigilance study in India
por: Manohar, Hasitha Diana, et al.
Publicado: (2016)

Pharmacovigilance in drugs used in the treatment of drug dependence
por: Thota, Anusha, et al.
Publicado: (2017)

Pharmacovigilance on drugs for headache and pain
Publicado: (2002)

Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis
Publicado: (2018)

Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database
por: Létinier, Louis, et al.
Publicado: (2021)

Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients
por: Zheng, Lei, et al.
Publicado: (2022)

Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
por: Liu, Yi, et al.
Publicado: (2023)

Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process
por: Suyagh, Maysa, et al.
Publicado: (2015)

3D Pharmacophoric Similarity improves Multi Adverse Drug Event Identification in Pharmacovigilance
por: Vilar, Santiago, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_au5l03qqlvjc0b594nuihkqn9i